Brief: Impedimed Says FY Net Loss Attributable A$19.9 Million

ImpediMed

29/08/2022 24:42

Aug 29 (Reuters) - ImpediMed  IPD.AX :
    * FY NET LOSS ATTRIBUTABLE A$19.9 MILLION VERSUS LOSS OF
A$20.7
MILLION
    * FY REVENUE FROM ORDINARY ACTIVITIES A$10.6 MILLION VERSUS
A$8.4
MILLION
    * THERE WERE NO DIVIDENDS DECLARED FOR FY

Source text for Eikon:  ID:nASX3zVxN5 
Further company coverage:  IPD.AX 

 ((Reuters.Briefs@thomsonreuters.com;))